(Q46970772)

English

Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions

scientific article published in March 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Beatriz Goñi-Allo

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Mar'a Ramos

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Isabel Herv'as

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Berta Lasheras

4

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Norberto Aguirre

5

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

20

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

245-256

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Altered states: the clinical effects of Ecstasy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Bioenergetics and glutamate excitotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063264

21 January 2018

Identifiers

10.1177/0269881106063264

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16510482

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46970772&oldid=2140189357"